Rafferty Asset Management, LLC - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 421 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.00 and the average weighting 0.3%.

Quarter-by-quarter ownership
Rafferty Asset Management, LLC ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$8,992,100
+20.8%
74,180
+14.1%
0.05%
+26.2%
Q2 2023$7,444,258
+11.0%
65,004
+33.6%
0.04%
-6.7%
Q1 2023$6,704,878
-26.7%
48,646
-31.1%
0.04%
-41.6%
Q4 2022$9,152,754
+36.1%
70,634
+16.1%
0.08%
+6.9%
Q3 2022$6,724,000
+48.7%
60,831
+0.8%
0.07%
+71.4%
Q2 2022$4,522,000
-21.7%
60,327
-18.4%
0.04%
+23.5%
Q1 2022$5,773,000
-3.0%
73,893
+11.8%
0.03%
+9.7%
Q4 2021$5,953,000
+45.1%
66,111
+49.0%
0.03%
+10.7%
Q3 2021$4,102,000
+74.0%
44,359
+46.2%
0.03%
+86.7%
Q2 2021$2,358,000
-17.9%
30,332
-21.3%
0.02%
-25.0%
Q1 2021$2,871,000
+202.2%
38,524
+591.1%
0.02%
+122.2%
Q4 2020$950,000
-55.4%
5,574
-63.3%
0.01%
-65.4%
Q3 2020$2,132,000
+118.9%
15,181
+150.0%
0.03%
+85.7%
Q2 2020$974,000
+177.5%
6,072
+69.1%
0.01%
-6.7%
Q1 2020$351,000
-90.9%
3,590
-88.0%
0.02%
-74.6%
Q4 2019$3,849,000
-32.3%
29,828
-60.5%
0.06%
-33.7%
Q3 2019$5,688,000
-9.5%
75,514
+82.6%
0.09%
-19.1%
Q2 2019$6,283,000
+39.0%
41,347
+9.1%
0.11%
+50.7%
Q1 2019$4,519,00037,9140.07%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Perceptive Advisors 2,878,979$69,182,0007.27%
Eventide Asset Management 259,100$6,226,0000.97%
GLADE BROOK CAPITAL PARTNERS LLC 251,000$6,032,0000.93%
IMS Capital Management 32,215$774,0000.91%
Perceptive Advisors 350,000$8,413,0000.88%
Benchmark Capital Advisors 34,900$839,0000.58%
BECK CAPITAL MANAGEMENT, LLC 24,744$636,0000.49%
SABBY MANAGEMENT, LLC 352,100$8,461,0000.47%
Hatteras Alternative Mutual Funds, LLC 39,404$947,0000.46%
Potomac Capital Management, Inc. 22,100$531,0000.45%
View complete list of SAREPTA THERAPEUTICS INC shareholders